drugset / Trial / NCT00749333

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.

NCT00749333 ↗

Phase 1 Completed 108 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to determine how well tolerated and safe AZD8566 is at different dose levels. This study will also determine how AZD8566 is distributed around the body and how it leaves the body.

Timeline

Start
2008-08
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8566 Unknown — Oral

Indications

No indication recorded.